A detailed history of Fort Sheridan Advisors LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Fort Sheridan Advisors LLC holds 63,672 shares of ABBV stock, worth $12.8 Million. This represents 1.78% of its overall portfolio holdings.

Number of Shares
63,672
Previous 45,383 40.3%
Holding current value
$12.8 Million
Previous $8.26 Million 32.15%
% of portfolio
1.78%
Previous 1.57%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$154.79 - $180.76 $2.83 Million - $3.31 Million
18,289 Added 40.3%
63,672 $10.9 Million
Q1 2024

May 15, 2024

BUY
$159.82 - $182.1 $434,710 - $495,312
2,720 Added 6.38%
45,383 $8.26 Million
Q3 2023

Nov 08, 2023

BUY
$133.59 - $154.65 $294,833 - $341,312
2,207 Added 5.46%
42,663 $6.36 Million
Q2 2023

Aug 01, 2023

BUY
$132.51 - $164.9 $343,333 - $427,255
2,591 Added 6.84%
40,456 $5.45 Million
Q1 2023

May 12, 2023

BUY
$144.61 - $166.54 $2.52 Million - $2.9 Million
17,410 Added 85.11%
37,865 $6.03 Million
Q4 2022

Feb 15, 2023

SELL
$138.31 - $165.87 $76,347 - $91,560
-552 Reduced 2.63%
20,455 $3.31 Million
Q3 2022

Nov 09, 2022

BUY
$134.21 - $153.93 $69,252 - $79,427
516 Added 2.52%
21,007 $2.82 Million
Q2 2022

Aug 08, 2022

SELL
$137.62 - $174.96 $10,321 - $13,122
-75 Reduced 0.36%
20,491 $3.14 Million
Q1 2022

May 09, 2022

SELL
$131.98 - $163.75 $173,289 - $215,003
-1,313 Reduced 6.0%
20,566 $3.33 Million
Q4 2021

Feb 10, 2022

BUY
$107.43 - $135.93 $26,535 - $33,574
247 Added 1.14%
21,879 $2.96 Million
Q3 2021

Nov 12, 2021

BUY
$106.4 - $120.78 $192,584 - $218,611
1,810 Added 9.13%
21,632 $2.33 Million
Q2 2021

Aug 17, 2021

BUY
$105.21 - $117.21 $139,929 - $155,889
1,330 Added 7.19%
19,822 $2.23 Million
Q1 2021

May 17, 2021

BUY
$102.3 - $112.62 $542,803 - $597,561
5,306 Added 40.24%
18,492 $2 Million
Q4 2020

Feb 16, 2021

BUY
$80.49 - $108.67 $140,294 - $189,411
1,743 Added 15.23%
13,186 $1.41 Million
Q3 2020

Nov 13, 2020

BUY
$85.91 - $100.83 $2,835 - $3,327
33 Added 0.29%
11,443 $1 Million
Q2 2020

Aug 14, 2020

BUY
$73.37 - $98.18 $8,657 - $11,585
118 Added 1.04%
11,410 $1.12 Million
Q1 2020

May 12, 2020

BUY
$64.5 - $97.79 $39,022 - $59,162
605 Added 5.66%
11,292 $860,000
Q4 2019

Feb 14, 2020

BUY
$72.13 - $90.25 $265,582 - $332,300
3,682 Added 52.56%
10,687 $946,000
Q3 2019

Nov 12, 2019

BUY
$62.98 - $75.72 $151,277 - $181,879
2,402 Added 52.18%
7,005 $530,000
Q2 2019

Aug 14, 2019

BUY
$65.7 - $83.98 $302,417 - $386,559
4,603 New
4,603 $335,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $355B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Fort Sheridan Advisors LLC Portfolio

Follow Fort Sheridan Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fort Sheridan Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fort Sheridan Advisors LLC with notifications on news.